Aptamers and SELEX in chemistry & biology

Chemistry and Biology

Volumn 21, Issue 9, 2014, Pages 1055-1058

  Famulok, Michael ^a   Mayer, Günter ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C; APTAMER; BLOOD CLOTTING FACTOR 9A; LIGAND; PEGAPTANIB; THROMBIN; DEOXYRIBOZYME; NUCLEIC ACID; RIBOZYME;

BIOTECHNOLOGY; COMBINATORIAL CHEMISTRY; HUMAN; IN VITRO SELECTION; LIGAND BINDING; NONHUMAN; NUCLEOTIDE BINDING SITE; REVIEW; RIBOSWITCH; ANIMAL; CHEMISTRY; DIAGNOSTIC USE; DRUG SCREENING; HIGH THROUGHPUT SCREENING; METABOLISM; NEOPLASMS;

ANIMALS; APTAMERS, NUCLEOTIDE; DNA, CATALYTIC; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; NEOPLASMS; NUCLEIC ACIDS; RNA, CATALYTIC; SELEX APTAMER TECHNIQUE; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84910007230     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chembiol.2014.08.003     Document Type: Review

References (39)

1. Breaker, R.R., and Joyce, G.F. (1994). A DNA enzyme that cleaves RNA. Chem. Biol. 1, 223-229.
2. Burmeister, P.E., Lewis, S.D., Silva, R.F., Preiss, J.R., Horwitz, L.R., Pendergrast, P.S., McCauley, T.G., Kurz, J.C., Epstein, D.M., Wilson, C., and Keefe, A.D. (2005). Direct in vitro selection of a 2′-O-methyl aptamer to VEGF. Chem. Biol. 12, 25-33.
3. Carmi, N., Shultz, L.A., and Breaker, R.R. (1996). In vitro selection of self-cleaving DNAs. Chem. Biol. 3, 1039-1046.
4. Fusz, S., Eisenführ, A., Srivatsan, S.G., Heckel, A., and Famulok, M. (2005). A ribozyme for the aldol reaction. Chem. Biol. 12, 941-950.
5. Gold, L., Ayers, D., Bertino, J., Bock, C., Bock, A., Brody, E.N., Carter, J., Dalby, A.B., Eaton, B.E., Fitzwater, T., et al. (2010). Aptamer-based multiplexed proteomic technology for biomarker discovery. PLoS ONE 5, e15004.
6. Green, L.S., Jellinek, D., Bell, C., Beebe, L.A., Feistner, B.D., Gill, S.C., Jucker, F.M., and Janjić, N. (1995). Nuclease-resistant nucleic acid ligands to vascular permeability factor/vascular endothelial growth factor. Chem. Biol. 2, 683-695.
7. Hoellenriegel, J., Zboralski, D., Maasch, C., Rosin, N.Y., Wierda, W.G., Keating, M.J., Kruschinski, A., and Burger, J.A. (2014). The Spiegelmer NOXA12, a novel CXCL12 inhibitor, interferes with chronic lymphocytic leukemia cell motility and causes chemosensitization. Blood 123, 1032-1039.
8. Jäger, S., Rasched, G., Kornreich-Leshem, H., Engeser, M., Thum, O., and Famulok, M. (2005). A versatile toolbox for variable DNA functionalization at high density. J. Am. Chem. Soc. 127, 15071-15082.
9. Jenne, A., and Famulok, M. (1998). A novel ribozyme with ester transferase activity. Chem. Biol. 5, 23-34.
10. Joyce, G.F., and Breaker, R.R. (2014). The expanding view of RNA and DNA function. Chem. Biol. 21, this issue, 1059-1065.
11. Keefe, A.D., Pai, S., and Ellington, A. (2010). Aptamers as therapeutics. Nat. Rev. Drug Discov. 9, 537-550.
12. Kim, D.E., and Joyce, G.F. (2004). Cross-catalytic replication of an RNA ligase ribozyme. Chem. Biol. 11, 1505-1512.
13. Kimoto, M., Yamashige, R., Matsunaga, K., Yokoyama, S., and Hirao, I. (2013). Generation of high-affinity DNA aptamers using an expanded genetic alphabet. Nat. Biotechnol. 31, 453-457.
14. Lato, S.M., Boles, A.R., and Ellington, A.D. (1995). In vitro selection of RNA lectins: using combinatorial chemistry to interpret ribozyme evolution. Chem. Biol. 2, 291-303.
15. Levy, M., and Ellington, A.D. (2002). ATP-dependent allosteric DNA enzymes. Chem. Biol. 9, 417-426.
16. Mi, J., Liu, Y., Rabbani, Z.N., Yang, Z., Urban, J.H., Sullenger, B.A., and Clary, B.M. (2010). In vivo selection of tumor-targeting RNA motifs. Nat. Chem. Biol. 6, 22-24.
17. Müller, J., Isermann, B., Dücker, C., Salehi, M., Meyer, M., Friedrich, M., Madhusudhan, T., Oldenburg, J., Mayer, G., and Pötzsch, B. (2009). An exosites-pecific ssDNA aptamer inhibits the anticoagulant functions of activated protein C and enhances inhibition by protein C inhibitor. Chem. Biol. 16, 442-451.
18. Müller, J., Becher, T., Braunstein, J., Berdel, P., Gravius, S., Rohrbach, F., Oldenburg, J., Mayer, G., and Pötzsch, B. (2011). Profiling of active thrombin in human blood by supramolecular complexes. Angew. Chem. Int. Ed. Engl. 50, 6075-6078.
19. Müller, J., Friedrich, M., Becher, T., Braunstein, J., Kupper, T., Berdel, P., Gravius, S., Rohrbach, F., Oldenburg, J., Mayer, G., and Pötzsch, B. (2012). Monitoring of plasma levels of activated protein C using a clinically applicable oligonucleotide-based enzyme capture assay. J. Thromb. Haemost. 10, 390-398.
20. Nahvi, A., Sudarsan, N., Ebert, M.S., Zou, X., Brown, K.L., and Breaker, R.R. (2002). Genetic control by a metabolite binding mRNA. Chem. Biol. 9, 1043.
21. Paige, J.S., Wu, K.Y., and Jaffrey, S.R. (2011). RNA mimics of green fluorescent protein. Science 333, 642-646.
22. Pastor, F., Kolonias, D., Giangrande, P.H., and Gilboa, E. (2010). Induction of tumour immunity by targeted inhibition of nonsense-mediated mRNA decay. Nature 465, 227-230.
23. Pinheiro, V.B., Taylor, A.I., Cozens, C., Abramov, M., Renders, M., Zhang, S., Chaput, J.C., Wengel, J., Peak-Chew, S.Y., McLaughlin, S.H., et al. (2012). Synthetic genetic polymers capable of heredity and evolution. Science 336, 341-344.
24. Pofahl, M., Wengel, J., and Mayer, G. (2014). Multifunctional nucleic acids for tumor cell treatment. Nucleic Acid Ther. 24, 171-177.
25. Ruckman, J., Green, L.S., Beeson, J., Waugh, S., Gillette, W.L., Henninger, D.D., Claesson-Welsh, L., and Janjíc, N. (1998). 2′-Fluoropyrimidine RNA-based aptamers to the 165-amino acid form of vascular endothelial growth factor (VEGF165). Inhibition of receptor binding and VEGF-induced vascular permeability through interactions requiring the exon 7-encoded domain. J. Biol. Chem. 273, 20556-20567.
26. Rusconi, C.P., Roberts, J.D., Pitoc, G.A., Nimjee, S.M., White, R.R., Quick, G., Jr., Scardino, E., Fay, W.P., and Sullenger, B.A. (2004). Antidote-mediated control of an anticoagulant aptamer in vivo. Nat. Biotechnol. 22, 1423-1428.
27. Schreiber, S.L., and Nicolaou, K. (1994). A new journal for an expanding field. Chem. Biol. (Suppl. 1 ), 1.
28. Seelig, B., and Jäschke, A. (1999). A small catalytic RNA motif with Diels-Alderase activity. Chem. Biol. 6, 167-176.
29. Sengle, G., Eisenführ, A., Arora, P.S., Nowick, J.S., and Famulok, M. (2001). Novel RNA catalysts for the Michael reaction. Chem. Biol. 8, 459-473.
30. Serganov, A., Yuan, Y.R., Pikovskaya, O., Polonskaia, A., Malinina, L., Phan, A.T., Hobartner, C., Micura, R., Breaker, R.R., and Patel, D.J. (2004). Structural basis for discriminative regulation of gene expression by adenine- and guanine-sensing mRNAs. Chem. Biol. 11, 1729-1741.
31. Tang, J., and Breaker, R.R. (1997). Rational design of allosteric ribozymes. Chem. Biol. 4, 453-459.
32. Travascio, P., Li, Y., and Sen, D. (1998). DNA-enhanced peroxidase activity of a DNA-aptamer-hemin complex. Chem. Biol. 5, 505-517.
33. Vater, A., and Klussmann, S. (2003). Toward third-generation aptamers: Spiegelmers and their therapeutic prospects. Curr. Opin. Drug Discov. Devel. 6, 253-261.
34. Vaught, J.D., Bock, C., Carter, J., Fitzwater, T., Otis, M., Schneider, D., Rolando, J., Waugh, S., Wilcox, S.K., and Eaton, B.E. (2010). Expanding the chemistry of DNA for in vitro selection. J. Am. Chem. Soc. 132, 4141-4151.
35. Wallis, M.G., von Ahsen, U., Schroeder, R., and Famulok, M. (1995). A novel RNA motif for neomycin recognition. Chem. Biol. 2, 543-552.
36. Wang, Y., and Rando, R.R. (1995). Specific binding of aminoglycoside antibiotics to RNA. Chem. Biol. 2, 281-290.
37. Wilson, C., and Szostak, J.W. (1998). Isolation of a fluorophore-specific DNA aptamer with weak redox activity. Chem. Biol. 5, 609-617.
38. Zhang, B., and Cech, T.R. (1998). Peptidyl-transferase ribozymes: trans reactions, structural characterization and ribosomal RNA-like features. Chem. Biol. 5, 539-553.
39. Zhu, G., Zheng, J., Song, E., Donovan, M., Zhang, K., Liu, C., and Tan, W. (2013). Self-assembled, aptamer-tethered DNA nanotrains for targeted transport of molecular drugs in cancer theranostics. Proc. Natl. Acad. Sci. U S A 110, 7998-8003.